International Journal of Biomedicine (IJBM) is an international, peer-reviewed, open access journal. IJBM publishes scientific articles related to basic, applied, and translational research in biology and medicine. International Journal of Biomedicine welcomes submissions of the following types of paper: Original articles, Reviews, Viewpoints, Case Reports, and Short Communications. IJBM articles released after April 1, 2026, are published under a Creative Commons Attribution–NonCommercial–NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
Information about the Publication Ethics and Editorial Policies is detailed here.
Editorial Procedures
IJBM’s editorial procedures are guided by the COPE Code of Conduct for Journal Editors. The editor also may be guided by the policies of the journal’s editorial board. Manuscripts are evaluated for their content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. IJBM is committed to following best practices on ethical matters, errors, and retractions, and to providing legal review if necessary.
Review Process
After manuscript submission, the Editor-in-Chief screens manuscripts for fit with the journal's scope and basic quality, and notifies the corresponding author whether it is under consideration for publication. The Editor-in-Chief may sometimes reject a manuscript without external peer review if the manuscript is outside the scope of IJBM or does not meet the journal’s quality standards. Articles under such consideration are sent to peer reviewers selected by the Editor-in-Chief or the Editorial Board members to whom the task has been delegated. Experts are usually not part of the editorial staff. The Editor-in-Chief or the Editorial Board members send confidential information to the reviewer with the invitation letter, which contains explicit instructions on the IJBM’s expectations for the scope, content, quality, and timeliness of their reviews to promote thoughtful, fair, constructive, and informative critique of the submitted manuscript. The Editor-in-Chief and Editorial Board members ensure that reviewers have access to all materials that may be relevant to the evaluation of the manuscript, including supplementary materials. Reviewers should clearly express their views, supported by arguments. If the reviewers recommend extensive revisions or have questions, authors may be asked to revise their manuscript and then resubmit the article. Reviewers are not allowed to make copies of the manuscript for their files. Reviewers should return or destroy copies of manuscripts after submitting reviews. The Editor-in-Chief oversees the entire peer-review process to ensure quality, ethical standards, and compliance with the journal’s scope. All articles in the IJBM are evaluated by the editor-in-chief, who makes final decisions (accept, reject, or revise) based on reviewer recommendations, expert assessments, and the journal's strategic goals. IJBM editors reserve the right to edit text for clarity, style, and length. Page proofs are sent to the authors electronically and must be returned within 72 hours to avoid delay of publication. Generally, peer review is completed within 6-8 weeks.
The Editor-in-Chief ensures ethical oversight, investigating allegations of plagiarism, falsification, or unethical research conduct. The Editor-in-Chief is the primary contact for authors.
Timeliness
Generally, peer review is completed within 4-6 weeks, and the editor’s decision is made within 7-14 days of this. It is therefore very rare to have to wait more than 8 weeks for a final decision.
Duties of Authors
IJBM accepts manuscripts that have not been published elsewhere and are not under consideration for publication by other print or electronic media. Authors must present an accurate account of the work performed as well as an objective discussion of its significance. The underlying data should be accurately represented in the paper. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. The authors should ensure that they have written entirely original works, and if they have used the work of others, that this has been appropriately cited. Manuscript should conform to the Uniform Requirements for Manuscript Submitted to Biomedical Journals, developed by the International Committee of Medical Journal Editors and available at http://www.icmje.org. Please review the section “For Authors.”
Authorship Statement
IIJBM follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), which state that only contributors who have made substantive intellectual contributions to a paper are credited as authors. Contributors credited as authors must understand their role in taking responsibility and being accountable for what is published. Contributors who do not meet all criteria for authorship should be listed in the Acknowledgements section.
The corresponding author serves as the primary liaison between the research team and the journal. The corresponding author, acting on behalf of all authors, is responsible for the entire contents, including the author list and statements regarding author contributions. Any changes to the author list after the submission of the manuscript—such as alterations to the author order, or the addition or removal of authors—must be approved by each author. The corresponding author is required to submit a statement regarding competing interests on behalf of all authors of the article. The corresponding author is also required to obtain and submit written permission for the reuse of materials from the authors of previous works and/or their publishers. Following the publication of the article, the corresponding author serves as the primary point of contact for addressing any inquiries regarding the published material.
Ethical Considerations in the Conduct and Reporting of Research: Protection of Human Subjects and Animals in Research
Studies involving human subjects or tissues must adhere to the Declaration of Helsinki and Title 45, US Code of Federal Regulations, Part 46, Protection of Human Subjects, and must have received approval of the appropriate institutional committee charged with oversight of human studies. Informed consent must be obtained. All research studies involving animals must have been conducted in accordance with animal welfare guidelines, such as the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals or equivalent documents.
Informed Consent
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is an inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that the alterations do not distort scientific meaning, and editors should note this. When informed consent has been obtained, it should be indicated in the submitted article.
Journal author guidelines (Instructions for Authors) can be found here.
